Table 1.
Characteristics of patients with AML
| Characteristic | AML |
|---|---|
| Number of patients | 24 |
| Median (range) age, year | 55 (21-65) |
| Median (range) white blood cell count (G/l) | 37.6 (9.9-199.5) |
| Median (range) of the blastic cells in peripheral blood | 85 (21-97) |
| Median (range) of the CD33 expression on blastic cells [%] | 89 (78-98) |
| AML according to FAB classification | 22 |
| AML, minimally differentiated, M0 | 7 |
| AML without maturation, M1 | 6 |
| AML with maturation, M2 | 5 |
| Acute myelomonocytic leukemia (AMMoL), M4 | 6 |
| Karyotype | 46XX/46XY |
| FLT3-ITD/NMP1mut/CEBPAmut | 0/0/0 |
| CR/NR | 12/12 |
Legends: AML- acute myeloid leukaemia, CR-complete remission, NPM1mut -mutated nucleophosmin, CEBPAmut - mutated core binding factor leukaemia, FLT3-ITD- internal tandem duplication of Fms-like tyrosine kinase 3.